Skip to Content
Orbitrex Peptides
Shop
COA
About
FAQs
Contact
(0)
Cart (0)
Orbitrex Peptides
Shop
COA
About
FAQs
Contact
(0)
Cart (0)
Shop
COA
About
FAQs
Contact
Shop KLOW 80
KLOW 80.jpeg Image 1 of
KLOW 80.jpeg
KLOW 80.jpeg

KLOW 80

$134.99
sold out

KLOW is a proprietary blend designed for research focused on tissue regeneration, cellular recovery, and neuro-endocrine optimization. Its composition is believed to engage multiple biological pathways including:

  • Collagen and elastin expression for skin, joint, and vascular studies

  • Neurotransmitter balance and stress modulation

  • Anti-inflammatory response and immune system regulation

  • Potential interaction with GH/IGF-1 and peptide signaling axes

The unique profile of KLOW makes it ideal for advanced biopeptide synergy studies across metabolic, musculoskeletal, and cognitive research fields.

Total Content: 80 mg per vial

  • BPC-157 – 10 mg

  • GHK-Cu – 50 mg

  • TB-500 – 10 mg

  • KPV – 10 mg

Add To Cart

KLOW is a proprietary blend designed for research focused on tissue regeneration, cellular recovery, and neuro-endocrine optimization. Its composition is believed to engage multiple biological pathways including:

  • Collagen and elastin expression for skin, joint, and vascular studies

  • Neurotransmitter balance and stress modulation

  • Anti-inflammatory response and immune system regulation

  • Potential interaction with GH/IGF-1 and peptide signaling axes

The unique profile of KLOW makes it ideal for advanced biopeptide synergy studies across metabolic, musculoskeletal, and cognitive research fields.

Total Content: 80 mg per vial

  • BPC-157 – 10 mg

  • GHK-Cu – 50 mg

  • TB-500 – 10 mg

  • KPV – 10 mg

KLOW is a proprietary blend designed for research focused on tissue regeneration, cellular recovery, and neuro-endocrine optimization. Its composition is believed to engage multiple biological pathways including:

  • Collagen and elastin expression for skin, joint, and vascular studies

  • Neurotransmitter balance and stress modulation

  • Anti-inflammatory response and immune system regulation

  • Potential interaction with GH/IGF-1 and peptide signaling axes

The unique profile of KLOW makes it ideal for advanced biopeptide synergy studies across metabolic, musculoskeletal, and cognitive research fields.

Total Content: 80 mg per vial

  • BPC-157 – 10 mg

  • GHK-Cu – 50 mg

  • TB-500 – 10 mg

  • KPV – 10 mg

Form: Lyophilized peptide blend
Purity: ≥99% (HPLC Verified)
Volume: Supplied in sterile 3 mL research vials
Storage Conditions:

  • Unreconstituted: Store at –20°C in a cool, dry place

  • Reconstituted: Store at 2–8°C for up to 30 days

  • Avoid exposure to light and repeated freeze-thaw cycles
    Intended Use: For in-vitro laboratory research only. Not for human or animal consumption.

KLOW is a synergistic blend of four high-purity peptides designed for advanced research in inflammation modulation, tissue regeneration, and systemic recovery. Each component plays a unique but complementary role:

  • BPC-157 (Body Protection Compound): A gastric-derived peptide studied for its effects on muscle, tendon, and vascular repair, angiogenesis, and gastrointestinal integrity.

  • GHK-Cu (Copper Tripeptide-1): A naturally occurring copper-binding peptide with strong roles in wound healing, collagen synthesis, anti-aging, and skin/tissue remodeling.

  • TB-500 (Thymosin Beta-4 Fragment): A synthetic analog of thymosin beta-4, involved in angiogenesis, inflammation regulation, and muscle regeneration by promoting cell migration and healing.

  • KPV (Lys-Pro-Val): A melanocortin-derived tripeptide with demonstrated anti-inflammatory, anti-microbial, and gut-protective properties, often researched in immune and skin inflammation models.

Orbitrex peptides

FAQ

Contact

support@orbitrexpeptides.com

FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Orbitrex Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. orbitrex Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.
© Copyright 2025. All Rights Reserved.